510(k) K223405

Access Testosterone by Beckman Coulter, Inc. — Product Code CDZ

K223405 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access Testosterone". The FDA issued a decision of Substantially Equivalent on Jan 13, 2023. The device falls under product code CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone), a Class I device regulated under 21 CFR 862.1680. Beckman Coulter, Inc. has 280 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 13, 2023
Date Received
Nov 9, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class
Class I
Regulation Number
862.1680
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Beckman Coulter, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K223405. Report a data issue: hello@regdatalab.com.